inVentiv Health Recognized As 'Clinical Company Of The Year'

inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, recently announced that, at a ceremony in London, inVentiv Health was named “Clinical Company of the Year” by PharmaTimes.

“This award recognizes the tremendous value that inVentiv Health brings to clients,” said Paul Meister, Chief Executive Officer of inVentiv Health. “By linking our Clinical segment with commercial and consulting groups, we are able to offer sophisticated, tailored services that no other CRO can match.”

In addition, inVentiv Health employee Adi Needham won “Clinical Trial Administrator of the Year.” Needham has been with inVentiv Health for two years and works as an Unmasked CRA placed at a major pharmaceutical company.

“Our status as a top global provider of CRO services is driven by the quality and dedication of our staff,” said Ray Hill, President of inVentiv Health. “Both the company and individual awards are a testament of the commitment that we have across the organization to our clients and the patients they serve.”

With 7,000 employees in more than 36 countries, inVentiv Health is uniquely positioned as a leading clinical research organization to offer healthcare companies worldwide services in Early Stage (Phase I), Phase II-III, Late Stage (Phase IV) clinical development and clinical staffing. These services can be deployed on any scale from highly complex multinational clinical trials to earlier stage studies involving specialized patient populations to Late Stage post-approval studies, or from placing a single individual at a company to outsourcing a full clinical department.

About inVentiv Health
inVentiv Health, formerly PharmaNet/i3, is a leading provider of global drug development services to pharmaceutical, biotechnology, generic drug, and medical device companies, offering therapeutically specialized capabilities for Phase I-IV clinical development, bioanalytical services, and strategic resourcing from a single clinical professional to an entire functional team. With 7,000 employees in more than 36 countries, inVentiv Health works to accelerate high quality drug development programs of all sizes around the world. For more information, visit http://www.inventivhealthclinical.com.

About inVentiv Health
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv offers convergent services that deliver extraordinary outcomes to clients whose goal is improving human life. In 40 countries around the world, inVentiv’s 13,000 employees help clients rapidly transform promising ideas into commercial reality. inVentiv clients include more than 550 pharmaceutical, biotech and life sciences companies, as well as companies that now see health as part of their mission. inVentiv Health, Inc. is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. For more information, visit http://www.inventivhealth.com.